MALZEVILLE, France

Céline Frochot


 

Average Co-Inventor Count = 8.0

ph-index = 1


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Céline Frochot: Innovator in Cancer Treatment

Introduction

Céline Frochot is a notable inventor based in Malzéville, France, recognized for his significant contributions to the field of medical innovations. With a focus on cancer treatment, he has pioneered advancements that harness the potential of photodynamic therapy through his patented invention.

Latest Patents

Frochot holds a patent for a compound known as Pyropheophorbide conjugate, which has undergone developments that enhance its application in cancer treatment. The invention encompasses a compound of formula (I) along with its pharmaceutically acceptable salts. This innovative compound is specifically designed for use in treating cancer, offering a potential to improve the efficacy of photodynamic therapy while also functioning as a fluorescent marker.

Career Highlights

Throughout his career, Céline Frochot has dedicated himself to the research and application of novel therapeutic methods to combat cancer. His focus on developing compounds that can be utilized both as therapeutic agents and diagnostic tools exemplifies his commitment to advancing medical science.

Collaborations

Frochot has collaborated with esteemed colleagues Henri Azais and Pierre Collinet, combining their expertise to explore and expand the applications of his patented invention. Their partnership underscores the importance of teamwork in scientific research, leading to innovative solutions to pressing medical challenges.

Conclusion

Céline Frochot's work represents a significant leap forward in cancer treatment methodologies. Through his patent and collaborative efforts, he continues to influence the landscape of medical innovation, offering hope for new therapeutic strategies in the fight against cancer. His contributions highlight the essential role of inventors in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…